StocksMediumUpdated×2•Originally published 12 November 2026•Updated 12 November 2026•
1 min read
LifeMD Beats Q3 Earnings Estimates Despite Revenue Miss and Widening Loss
Key Facts
1LifeMD reported third quarter 2026 revenue of $44.6 million.
2Adjusted EBITDA loss was approximately $0.4 million, falling within the company's guidance range.
3Adjusted EBITDA improved by $3.1 million sequentially, driven by a 34% reduction in selling and marketing expenses.
LifeMD reported third-quarter 2026 earnings per share that beat analyst estimates by $0.04, according to GlobeNewswire. The company posted revenue of $44.6 million, which fell short of market expectations, while the net loss for the period widened.
The company attributed its financial performance improvements to growth in branded GLP-1 fulfillment and tighter cost controls. LifeMD stated its adjusted EBITDA reflected a sequential improvement of $3.1 million driven by a 34% cut in marketing expenses, while LFMD closed at $1.78 on November 11, 2026.